Yuheng Pharmaceutical announced that the company's deputy general manager Li Runbao, Wang Xiaohang, and Liu Yueyin, director, deputy general manager and board secretary, have completed the implementation of the holdings reduction plan. Li Runbao and Wang Xiaohang each reduced their holdings by 587,500 shares, each accounting for 0.03% of the company's total shares; Liu Yueyin reduced their holdings by 259,600 shares, accounting for 0.01% of the company's total shares. The price range for reduced holdings was 2.9 yuan/share to 2.92 yuan/share. After the holdings were reduced, Li Runbao held 1.762,500 shares, accounting for 0.08% of the total share capital; Wang Xiaohang held 1.762,500 shares, accounting for 0.08% of the total share capital; and Liu Yueyin held 778,900 shares, accounting for 0.03% of the total share capital.

Yuheng Pharmaceutical announced that the company's deputy general manager Li Runbao, Wang Xiaohang, and Liu Yueyin, director, deputy general manager and board secretary, have completed the implementation of the holdings reduction plan. Li Runbao and Wang Xiaohang each reduced their holdings by 587,500 shares, each accounting for 0.03% of the company's total shares; Liu Yueyin reduced their holdings by 259,600 shares, accounting for 0.01% of the company's total shares. The price range for reduced holdings was 2.9 yuan/share to 2.92 yuan/share. After the holdings were reduced, Li Runbao held 1.762,500 shares, accounting for 0.08% of the total share capital; Wang Xiaohang held 1.762,500 shares, accounting for 0.08% of the total share capital; and Liu Yueyin held 778,900 shares, accounting for 0.03% of the total share capital.